UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000044626
Receipt No. R000050974
Scientific Title The effect of intravenous ibuprofen on postoperative pain and opioid consumption after pediatric cardiac surgery: A randomized, double-blind, controlled study
Date of disclosure of the study information 2021/08/01
Last modified on 2021/06/23 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The effect of intravenous ibuprofen on postoperative pain and opioid consumption after pediatric cardiac surgery
Acronym The effect of intravenous ibuprofen on postoperative pain and opioid consumption after pediatric cardiac surgery: A randomized, double-blind, controlled study
Scientific Title The effect of intravenous ibuprofen on postoperative pain and opioid consumption after pediatric cardiac surgery: A randomized, double-blind, controlled study
Scientific Title:Acronym The effect of intravenous ibuprofen on postoperative pain and opioid consumption after pediatric cardiac surgery: A randomized, double-blind, controlled study
Region
Africa

Condition
Condition efficacy of intravenous ibuprofen on postoperative pain
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to evaluate the effect of intravenous ibuprofen on postoperative analgesia after pediatric cardiac surgery
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes measure of this randomized study is the total dose of fentanyl requirements in the first postoperative 24 hours
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control No treatment
Stratification YES
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 intravenous ibuprofen
Interventions/Control_2 placebo
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
2 years-old <=
Age-upper limit
12 years-old >=
Gender Male and Female
Key inclusion criteria patient submitted for on pump elective repair of congenital simple left to right intra cardiac shunt via median sternotomy
Key exclusion criteria case of refusal of their guardians
redo cardiac surgery
hypersensitivity to ibuprofen
coagulation disorders
renal, hepatic or pulmonary disease
heart failure and moderate to severe pulmonary hypertension.
Target sample size 80

Research contact person
Name of lead principal investigator
1st name Ibrahim
Middle name Ibrahim
Last name Abd Elbaser
Organization Faculty of Medicine, Mansoura University
Division name ANAETHETSIA AND INTENSIVE CARE DEPARTMENT
Zip code 53333
Address 12 saad zaghloul street
TEL +447534268934
Email ibrahimbaser@yahoo.com

Public contact
Name of contact person
1st name HANI
Middle name
Last name TAMAN
Organization MANSOURA FACULTY OF MEDICINE, MANSOURA UNIVERSITY, EGYPT
Division name ANAETHETSIA AND INTENSIVE CARE DEPARTMENT
Zip code CF470JF
Address 2 CLOS PWLL GLO
TEL +447534268934
Homepage URL
Email hani_taman@yahoo.com

Sponsor
Institute Faculty of Medicine, Mansoura University
Institute
Department

Funding Source
Organization Faculty of Medicine, Mansoura University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization United Kingdom

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization MEDICAL RESEARCH ETHICS COMMITTEE, INSTITUTIONAL REVIEW BOARD, MANSOURA UNIVERSITY
Address 12 saad zaghloul street
Tel +201092127930
Email IRB.MFM@hotmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 80
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 05 Month 01 Day
Date of IRB
2020 Year 06 Month 15 Day
Anticipated trial start date
2020 Year 07 Month 01 Day
Last follow-up date
2021 Year 06 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 06 Month 23 Day
Last modified on
2021 Year 06 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050974